Pharmaco International Ltd, Bangladesh signed a Memorandum of Understanding (MOU) with Glen Copel Pharmaceutical Inc USA recently for the formation of a joint Venture Company in the name and style of Pharmaco-Glen Copel Pharmaceutical Ltd.
The Memorandum of Understanding (MOU) has been signed by Dr Ricky on behalf of Glen Copel Pharmaceutical USA and Dr Matin of Pharmaco International Ltd, Bangladesh. Ricky and Amjad Hossain were present on the signing ceremony on behalf of the respective companies.
This joint venture will enable to produce life saving and specialised drugs and medicines towards making the country self sufficient, to save and earn foreign exchange by exporting the drugs to be produced, the press release added
Immunization Profile - Bangladesh
Developement status:
Least developed
GNP / capita (US$):1
Infant (under 12 months) mortality rate:2§
GDP / capita (US$):1
1,602
Child (under 5 years) mortality rate:2§
Population data in thousands 2
2001
2000
1999
1998
1997
1990
1980
Live births
4,284
4,217
4,150
4,097
4,072
4,066
3,593
Female 15-49 years
34,780
33,831
32,881
31,935
31,003
25,358
18,634
Pop. less than 15 years
53,727
53,190
52,682
52,191
51,689
46,313
37,732
Pop. less than 5 years
18,871
18,652
18,516
18,450
18,423
17,503
14,285
Surviving infants
4,024
3,956
3,894
3,852
3,836
3,787
3,241
Total population
140,369
137,439
134,584
131,797
129,058
110,025
85,438
Number of reported cases
Diphtheria
1,559
Measles
4,414
5,098
5,666
6,522
10,329
1,705
11,077
Pertussis
4,879
12,436
Polio
Tetanus (neonatal)
1,068
Tetanus (total)
1,221
1,155
1,814
1,991
3,129
2,511
2,855
Yellow fever
Percentage of target population vaccinated, by antigen
Hovering over an antigen reveals its fuller definition
Last coverage survey 3
WHO-UNICEF 4
Official country estimates 5
Year
Result
Estimates 2001
2000
94 EPI Cluster
DTP1
2000
93 EPI Cluster
DTP3
2000
83 EPI Cluster
HepB3
Hib3
2000
76 EPI Cluster
Pol3
2000
83 EPI Cluster
TT2plus
2000
- EPI Cluster
VitA
Number of districts in the country
Percentage reporting completeness, DTP3 coverage
Proportion of
districts reporting
DTP3 coverage of
Greater or equal to 80%
88 %
From 50 to 79%
11 %
Lesser or equal to 50%
Not reporting DTP3 coverage